This project team will create a White Paper with recommendations for adverse event collection instructions, with a focus on Phase 2-4 clinical trials. This White Paper will build upon a paper that outlines results from a survey on current practices, indicating variation that can likely be reduced. Recommendations will be based on the desired end-in-mind, and may or may not be consistent with current practices
Project Leads: